---
schema_version: "secwatch.filing_event.v1"
accession: "0001609550-24-000024"
form_type: "8-K"
ticker: "INSP"
cik: "0001609550"
company_name: "Inspire Medical Systems, Inc."
filed_at: "2024-05-07T23:59:59+00:00"
generated_at: "2026-06-02T18:37:03.945894+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Inspire Medical Q1 revenue $164M (+28% YoY); raises FY2024 guidance, expects full-year profitability

## Summary
- Q1 2024 revenue $164.0M, up 28% YoY; net loss narrowed to $10.0M ($0.34/share) from $15.4M.
- U.S. revenue $155.8M (+25% YoY); OUS revenue $8.2M (+141%); gross margin 84.9% vs 84.4%.
- FY2024 revenue guidance raised to $783-793M (25-27% growth); first-time diluted EPS guidance $0.10-$0.20.
- Added 66 new U.S. centers (total 1,246) and 11 new sales territories (total 298) in Q1.
- Ended Q1 with $469.2M cash; expects full-year 2024 profitability.

## SEC filing metadata
- accession: 0001609550-24-000024
- form_type: 8-K
- ticker: INSP
- cik: 0001609550
- company_name: Inspire Medical Systems, Inc.
- filed_at: 2024-05-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1609550/000160955024000024/0001609550-24-000024-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1609550/000160955024000024/insp-20240507.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001609550-24-000024
- JSON: https://secwatch.observer/filing/0001609550-24-000024.json
- Plain text: https://secwatch.observer/filing/0001609550-24-000024.txt

## Key facts
- Earnings Releases
  Inspire Medical Systems, Inc. reported the full year 2024 results: revenue $783 million to $793 million. Guidance raised.
  - Period: the full year 2024
  - Revenue: $783 million to $793 million
  - Guidance: raised
  - Result: guidance update
  source text: Inspire is initiating first-time diluted net income per share guidance for the full year 2024 of between $0.10 to $0.20 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1609550/000160955024000024/0001609550-24-000024-index.htm
- Earnings Releases
  Inspire Medical Systems, Inc. reported the full year 2024 results: revenue $783 million to $793 million. Guidance raised.
  - Period: the full year 2024
  - Revenue: $783 million to $793 million
  - Guidance: raised
  - Result: guidance update
  source text: Inspire is increasing its full year 2024 revenue guidance to between $783 million to $793 million, which represents growth of 25% to 27% over full year 2023 revenue of $624.8 million.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1609550/000160955024000024/0001609550-24-000024-index.htm
- Earnings Releases
  Inspire Medical Systems, Inc. reported the quarter ended March 31, 2024 results: revenue $164.0 million, net income $10.0 million net loss, EPS $0.34 per share net loss per share.
  - Period: the quarter ended March 31, 2024
  - Revenue: $164.0 million
  - Net income: $10.0 million net loss
  - EPS: $0.34 per share net loss per share
  - Result: reported results
  source text: Revenue was $164.0 million for the three months ended March 31, 2024, a 28% increase from $127.9 million in the corresponding period in the prior year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1609550/000160955024000024/0001609550-24-000024-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.